Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (WO2012035124): a patent evaluation

Author： Costantino Luca  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.9, 2012-09, pp. : 1099-1104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth hormone secretagogue receptor antagonists

By Costantino Luca  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 697-700

Informa Healthcare

Access to resources Recommend Favorite

Growth Hormone Secretagogue (Ghrelin-) Receptors - A Complex Drug Target for the Regulation of Body Weight

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 335-343

Bentham Science Publishers

Access to resources Recommend Favorite

The Growth Hormone Secretagogue Receptor (Ghs-R)

By  

Current Pharmaceutical Design, Vol. 18, Iss. 31, 2012-10 ,pp. : 4749-4754

Bentham Science Publishers

Access to resources Recommend Favorite

Polymyxin derivatives: a patent evaluation (WO2012168820)

By Wu Haifan  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 1075-1081

Informa Healthcare

Access to resources Recommend Favorite

The prospects of antagonizing the growth hormone secretagogue receptor to treat obesity

By Zhao Hongyu   Serby Michael D   Liu Bo  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 989-998

Informa Healthcare

Access to resources Recommend Favorite